Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3954
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWieser, Simon-
dc.contributor.authorRüthemann, Isabelle-
dc.contributor.authorDe Boni, Sylvia Nadine-
dc.contributor.authorEichler, Klaus-
dc.contributor.authorPletscher, Mark-
dc.contributor.authorRadovanovic, Dragana-
dc.contributor.authorUlle, Tanja-
dc.contributor.authorAuerbach, Holger-
dc.date.accessioned2018-08-29T08:46:17Z-
dc.date.available2018-08-29T08:46:17Z-
dc.date.issued2012-
dc.identifier.issn1424-7860de_CH
dc.identifier.issn1424-3997de_CH
dc.identifier.issn0036-7672de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/9867-
dc.description.abstractQuestions under Study: To perform a cost-of-illness study of acute coronary syndrome (ACS) in Switzerland from a societal perspective, evaluating direct costs, production losses and intangible costs in terms of Quality adjusted life years (QALYs) lost. Methods: A bottom-up incidence-based approach was used. Data concerning patients with one or more ACS events were extracted from a national hospital database and from mortality statistics. Inpatient costs included acute care and rehabilitation. Outpatient costs included costs for ambulance, visits to GP and cardiologist, outpatient diagnostics, medication and rehabilitation. Production losses included absenteeism, permanent disability and premature death. Intangible costs were calculated on previously published QALY weights. Cost data were derived from official price lists, literature and experts. Future costs and QALYs lost were discounted. Results: In 2008 14,955 patients experienced a total of 16,815 ACS events; 2,752 died as a consequence of these. The resulting 19,064 hospital stays had an average acrosshospital length of stay of 9.1 days per patient. Total direct costs of ACS amounted to 630 Mio Swiss Francs (CHF) for society and CHF 462 Mio for health insurers. Total direct costs were dominated by costs of myocardial infarction: ST-elevation 45.8%, non-ST-elevation 35.8%. Production losses were CHF 519 Mio and intangible costs resulted in 49,878 QALYs lost. Conclusions: ACS causes considerable costs in terms of direct medical expenditures, lost production, suffering and premature death, even without taking into account costs for its chronic consequences such as congestive heart failure.de_CH
dc.language.isoende_CH
dc.publisherEMH Schweizerischer Ärzteverlagde_CH
dc.relation.ispartofSwiss Medical Weeklyde_CH
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/de_CH
dc.subjectAcute coronary syndromede_CH
dc.subjectAdultde_CH
dc.subjectAgedde_CH
dc.subjectAmbulancede_CH
dc.subjectEfficiencyde_CH
dc.subjectFemalede_CH
dc.subjectHealth care costde_CH
dc.subjectHospital mortalityde_CH
dc.subjectHumansde_CH
dc.subjectLength of stayde_CH
dc.subjectMalede_CH
dc.subjectMiddle agedde_CH
dc.subjectMyocardial infarctionde_CH
dc.subjectQuality-adjusted life yearde_CH
dc.subjectSwitzerlandde_CH
dc.subjectYoung adultde_CH
dc.subjectAbsenteeismde_CH
dc.subjectCost of illnessde_CH
dc.subjectGesunheitsökonomiede_CH
dc.subjectKostende_CH
dc.subjectAkutes Koronarsyndromde_CH
dc.subjectSchweizde_CH
dc.subject.ddc338: Produktionde_CH
dc.subject.ddc616: Innere Medizin und Krankheitende_CH
dc.titleCost of acute coronary syndrome in Switzerland in 2008de_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
zhaw.organisationalunitWinterthurer Institut für Gesundheitsökonomie (WIG)de_CH
dc.identifier.doi10.21256/zhaw-3954-
dc.identifier.doi10.4414/smw.2012.13655de_CH
dc.identifier.pmid22915246de_CH
zhaw.funding.euNode_CH
zhaw.issuew13655de_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume142de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedAngewandte Gerontologiede_CH
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
Cost of acute coronry syndrome_2012_SC1.1.pdf811.16 kBAdobe PDFThumbnail
View/Open
Show simple item record
Wieser, S., Rüthemann, I., De Boni, S. N., Eichler, K., Pletscher, M., Radovanovic, D., Ulle, T., & Auerbach, H. (2012). Cost of acute coronary syndrome in Switzerland in 2008. Swiss Medical Weekly, 142(w13655). https://doi.org/10.21256/zhaw-3954
Wieser, S. et al. (2012) ‘Cost of acute coronary syndrome in Switzerland in 2008’, Swiss Medical Weekly, 142(w13655). Available at: https://doi.org/10.21256/zhaw-3954.
S. Wieser et al., “Cost of acute coronary syndrome in Switzerland in 2008,” Swiss Medical Weekly, vol. 142, no. w13655, 2012, doi: 10.21256/zhaw-3954.
WIESER, Simon, Isabelle RÜTHEMANN, Sylvia Nadine DE BONI, Klaus EICHLER, Mark PLETSCHER, Dragana RADOVANOVIC, Tanja ULLE und Holger AUERBACH, 2012. Cost of acute coronary syndrome in Switzerland in 2008. Swiss Medical Weekly. 2012. Bd. 142, Nr. w13655. DOI 10.21256/zhaw-3954
Wieser, Simon, Isabelle Rüthemann, Sylvia Nadine De Boni, Klaus Eichler, Mark Pletscher, Dragana Radovanovic, Tanja Ulle, and Holger Auerbach. 2012. “Cost of Acute Coronary Syndrome in Switzerland in 2008.” Swiss Medical Weekly 142 (w13655). https://doi.org/10.21256/zhaw-3954.
Wieser, Simon, et al. “Cost of Acute Coronary Syndrome in Switzerland in 2008.” Swiss Medical Weekly, vol. 142, no. w13655, 2012, https://doi.org/10.21256/zhaw-3954.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.